EUVIMEDEUVIMED entdecken
Crossref

Efficacy of Topical Therapy with 200μg/mL Amphotericin B Solution After Functional Endoscopic Sinus Surgery in Patients of Allergic Fungal Rhinosinusitis

Divya Vaid, Aryan Arora, Vashi Gupta, Asmita Chanda, Neelima Gupta, Vipin Arora

International Journal of Pharmaceutical Quality Assurance · 28.02.2026 · 17 (2)

DOI: 10.25258/ijpqa.17.2.33 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 28.02.2026. Verfasst von Divya Vaid und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Most of the previous studies with topical amphotericin B (AmB) have been done in chronic rhinosinusitis (CRS) patients with controversial results and studies targeting the discrete subgroup of allergic fungal rhinosinusitis (AFRS) are lacking. The purpose of the present study has been to evaluate and compare the efficacies of intranasal lavage by 200μg/mL AmB solution versus normal saline in AFRS patients after functional endoscopic sinus surgery (FESS). Materials and Methods: Sixty adult AFRS patients were divided postoperatively into two groups for intranasal lavage: group A with normal saline (control) and group B with 200μg/mL AmB solution (intervention). Symptom and nasal endoscopy scores were calculated and assessed in both the groups preoperatively, at 2 weeks, 1 month and 3 months follow-up along with recurrence post-surgery.

Results

In group A, there were marked improvement in the mean symptom and nasal endoscopy scores at 2 weeks follow-up from the preoperative scores. Symptom scores deteriorated slightly at 1 and at 3 months followup while nasal endoscopy scores improved at 1 month and further at the end of 3 months. Similarly, group B showed significant improvement in the both the symptom and nasal endoscopy scores at 2 weeks. Mean symptom score deteriorated at 1 and 3 months follow-up while mean nasal endoscopy score improved at 1 month but deteriorated at 3 months follow-up. The intergroup differences were not significant. In group A, 46.66% patients had recurrence whereas in Group B, 70.0% had recurrence.

Conclusion

We concluded that although there was a definite improvement in both the groups after 3 months, post-FESS intranasal lavage with 200µg/mL of AmB, a higher dose than conventionally used, did not confer a greater benefit as compared to normal saline irrigation. Clinical Significance: Efficacy of post operative topical AmB therapy, even in higher concentration, is no better than that with normal saline when studied exclusively in patients of AFRS.

Zitieren

APA

Vaid, D., Arora, A., Gupta, V., Chanda, A., Gupta, N., & Arora, V. (2026). Efficacy of Topical Therapy with 200μg/mL Amphotericin B Solution After Functional Endoscopic Sinus Surgery in Patients of Allergic Fungal Rhinosinusitis. International Journal of Pharmaceutical Quality Assurance, 17(2). https://doi.org/10.25258/ijpqa.17.2.33

Vancouver

Vaid D, Arora A, Gupta V, Chanda A, Gupta N, Arora V. Efficacy of Topical Therapy with 200μg/mL Amphotericin B Solution After Functional Endoscopic Sinus Surgery in Patients of Allergic Fungal Rhinosinusitis. International Journal of Pharmaceutical Quality Assurance. 2026;17(2). doi:10.25258/ijpqa.17.2.33

BibTeX
@article{Vaid2026,
  author = {Vaid, Divya and Arora, Aryan and Gupta, Vashi and Chanda, Asmita and Gupta, Neelima and Arora, Vipin},
  title = {Efficacy of Topical Therapy with 200μg/mL Amphotericin B Solution After Functional Endoscopic Sinus Surgery in Patients of Allergic Fungal Rhinosinusitis},
  journal = {International Journal of Pharmaceutical Quality Assurance},
  year = {2026},
  volume = {17},
  number = {2},
  doi = {10.25258/ijpqa.17.2.33}
}
Kostenlos starten →